Scinai Immunotherapeutics... (SCNI)
NASDAQ: SCNI
· Real-Time Price · USD
1.73
0.20 (12.70%)
At close: Aug 21, 2025, 3:59 PM
1.68
-2.89%
After-hours: Aug 21, 2025, 07:59 PM EDT
Scinai Immunotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 10.49M | -2.32M | -2.16M | -2.33M | 3.11M | -3.76M | -3.52M | -528.81K | 1.05M | -2.98M | -2.48M | 1.19M | -2.8M | -3.68M | -2.45M |
Depreciation & Amortization | 498K | 494.19K | 156K | 84.91K | 145K | 147K | 138K | n/a | n/a | 145K | 134K | -114.47K | 189.24K | 185.16K | 180.93K |
Stock-Based Compensation | 145K | 142K | 191K | 453K | 234K | 200K | 252K | 1.6M | n/a | 385K | 485K | 648.2K | 783.78K | 789.76K | 435.73K |
Other Working Capital | -51K | 39K | -238K | 4.16M | -824K | 2.59M | -2.95M | n/a | n/a | -518K | 80K | 680.9K | -182.43K | 30.36K | 117.83K |
Other Non-Cash Items | -13.11M | 46.81K | 438K | -3.39M | -4.79M | -2.03M | 2.98M | -1.07M | -1.05M | -686K | 548K | -4.2M | -281.19K | 918.97K | 341.83K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -53K | -119K | -89K | 3.95M | -914K | 2.56M | -2.92M | n/a | n/a | -526K | 203K | 820.92K | 186.41K | -641.62K | 334.05K |
Operating Cash Flow | -2.04M | -1.76M | -1.46M | -1.23M | -2.22M | -2.88M | -3.06M | n/a | n/a | -3.67M | -1.1M | -1.65M | -1.92M | -2.43M | -1.16M |
Capital Expenditures | -4K | -6.01K | -2K | -234K | -20K | -377K | -6K | n/a | n/a | 35K | -521K | -92.28K | -1.43K | -32.51K | -6.58K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.68K | -2.79K | -306.7 | 11.06K |
Investing Cash Flow | -4K | -6K | -2K | -234K | -20K | -377K | -6K | n/a | n/a | 35K | -521K | -105.24K | -4.03K | -32.82K | 4.49K |
Debt Repayment | n/a | n/a | n/a | n/a | -2.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -95.22K | -97.22K | -91.51K |
Common Stock Repurchased | n/a | n/a | n/a | -947K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8K | 12K | 1.42M | 947K | 1.09M | n/a | 6.93K | n/a | n/a | n/a | n/a | 8.4M | -211.22K | n/a | 12.6M |
Financial Cash Flow | 8K | 12K | 1.42M | n/a | 1.09M | n/a | 6.93K | n/a | n/a | n/a | n/a | 8.4M | -306.44K | -97.22K | 12.51M |
Net Cash Flow | -2.04M | -1.75M | -44K | -1.47M | -1.15M | -3.29M | 10.93M | n/a | -11.42M | -4.11M | -1.99M | 6.76M | -1.48M | -2.3M | 11.6M |
Free Cash Flow | -2.04M | -1.76M | -1.47M | -1.46M | -2.24M | -3.25M | -3.06M | n/a | n/a | -3.63M | -1.63M | -1.75M | -1.92M | -2.46M | -1.16M |